Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Leamon

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Folate-targeted drug strategies for the treatment of cancerChristopher P Leamon
Therapeutic Advances in Medical Oncology|July 3, 2015
Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumorsIgnace Vergote, Christopher P Leamon
Bioconjugate Chemistry|June 7, 2012
Engineering folate-drug conjugates to target cancer: from chemistry to clinicIontcho R Vlahov, Christopher P Leamon
Advanced Drug Delivery Reviews|April 20, 2004
Folate-targeted chemotherapyChristopher P Leamon, Joseph A Reddy
Vitamins and Hormones|September 23, 2008
Exploitation of the folate receptor in the management of cancer and inflammatory diseaseChristopher P Leamon, Ann L Jackman
Pharmacogenomics and Personalized Medicine|October 11, 2013
Patient selection and targeted treatment in the management of platinum-resistant ovarian cancerChristopher P Leamon, Chandra D Lovejoy, Binh Nguyen
Bioconjugate Chemistry|July 17, 2003
Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivoChristopher P Leamon, Scott R Cooper, Gregory E Hardee
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 3, 2014
The folate receptor as a rational therapeutic target for personalized cancer treatmentYehuda G Assaraf, Christopher P Leamon, Joseph A Reddy
Molecular Cancer Therapeutics|September 14, 2013
177Lu-EC0800 combined with the antifolate pemetrexed: preclinical pilot study of folate receptor targeted radionuclide tumor therapyJosefine Reber, Stephanie Haller, Christopher P Leamon, et al.
Advanced Drug Delivery Reviews|April 20, 2004
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potentialYingjuan Lu, Emanuela Sega, Christopher P Leamon, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Folate-targeted drug strategies for the treatment of cancerChristopher P Leamon
Therapeutic Advances in Medical Oncology|July 3, 2015
Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumorsIgnace Vergote, Christopher P Leamon
Bioconjugate Chemistry|June 7, 2012
Engineering folate-drug conjugates to target cancer: from chemistry to clinicIontcho R Vlahov, Christopher P Leamon
Advanced Drug Delivery Reviews|April 20, 2004
Folate-targeted chemotherapyChristopher P Leamon, Joseph A Reddy
Vitamins and Hormones|September 23, 2008
Exploitation of the folate receptor in the management of cancer and inflammatory diseaseChristopher P Leamon, Ann L Jackman
Pharmacogenomics and Personalized Medicine|October 11, 2013
Patient selection and targeted treatment in the management of platinum-resistant ovarian cancerChristopher P Leamon, Chandra D Lovejoy, Binh Nguyen
Bioconjugate Chemistry|July 17, 2003
Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivoChristopher P Leamon, Scott R Cooper, Gregory E Hardee
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 3, 2014
The folate receptor as a rational therapeutic target for personalized cancer treatmentYehuda G Assaraf, Christopher P Leamon, Joseph A Reddy
Molecular Cancer Therapeutics|September 14, 2013
177Lu-EC0800 combined with the antifolate pemetrexed: preclinical pilot study of folate receptor targeted radionuclide tumor therapyJosefine Reber, Stephanie Haller, Christopher P Leamon, et al.
Advanced Drug Delivery Reviews|April 20, 2004
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potentialYingjuan Lu, Emanuela Sega, Christopher P Leamon, et al.
Pageof 8